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We used physician sentinel surveillance to identify 25 
(7.7%) mild to severe infections with enterovirus D68 
(EV-D68) in children and adults among 325 outpatients 
with acute respiratory infections in Germany during 
August–October 2014. Results suggested low-level circu-
lation of enterovirus D68 in Germany. Viruses were char-
acterized by sequencing viral protein (VP) 1 and VP4/VP2 
genomic regions.
Enterovirus D68 (EV-D68) belongs to the family Picor-naviridae, genus Enterovirus, species Enterovirus D. 
Since its initial discovery in 1962 (1), EV-D68 infections 
in humans have been reported rarely. However, since 2008, 
clusters of acute respiratory infections (ARIs) associated 
with EV-D68 have been reported worldwide, including Eu-
rope (2–5).
During mid-August 2014–January 2015, the United 
States and Canada had nationwide outbreaks of EV-D68 
infections associated with severe respiratory disease (6,7). 
The US Centers for Disease Control and Prevention and 
state public health laboratories confirmed 1,153 persons 
in 49 states and the District of Columbia infected by EV-
D68 (8). Over the same period, >200 specimens tested 
were positive for EV-D68 throughout Canada (7). Clini-
cal symptoms ranged from mild to severe disease requiring 
intensive care and mechanical ventilation. Children were 
predominantly affected, in particular if they had asthma or 
wheezing (6,9). After ARIs, symptoms of neurologic ill-
ness or acute flaccid myelitis developed in an increasing 
number of children (10,11).
To describe EV-D68 circulation in a large country in 
Europe in the fall of 2014, we investigated specimens from 
patients with respiratory illness for EV-D68. This investi-
gation was conducted within the national outpatient ARI 
sentinel surveillance in Germany.
The Study
Nasal swab specimens from outpatients with influenza-like 
illness (ILI), ARI, or both were collected by sentinel phy-
sicians participating in sentinel surveillance in Germany 
during weeks 32–44 in 2014 and sent to the Robert Koch 
Institute (Berlin, Germany). All specimens were tested 
in parallel for respiratory viruses, including influenza vi-
ruses A and B, rhinovirus/enterovirus, respiratory syncy-
tial virus, adenovirus, and metapneumovirus by specific 
real-time reverse transcription PCRs (online Technical Ap-
pendix, http://wwwnc.cdc.gov/EID/article/21/5/14-1900-
Techapp1.pdf). The rhinovirus/enterovirus real-time PCR 
detected rhinovirus at a limit of detection of 26 copies/reac-
tion. EV-D68 was identified at a slightly lower sensitivity 
of 118 copies/reaction.
Rhinovirus/enterovirus–positive specimens were 
screened for EV-D68 by sequencing the viral protein (VP) 
4/VP2 gene regions. Rhinovirus/enterovirus–negative 
specimens and samples without sequencing results were 
additionally analyzed by using a specific EV-D68 PCR 
(12). VP4/VP2 and VP1 regions were sequenced (GenBank 
accession nos. KP189380–KP189403 and KP657730–
KP657747) for EV-D68–positive specimens.
Rhinovirus/enterovirus was detected in 44% (143/325) 
of the specimens; 98 were identified as rhinovirus types 
A–C and 25 as EV-D68. The remaining 20 specimens 
could not be subtyped, but were negative for EV-D68 by 
using the specific PCR. The proportion of EV-D68 cor-
responded to 7.7% of the study collective. EV-D68 was 
initially detected from week 36 (August) through 38 (Sep-
tember) and continuously from week 41 through week 44 
in October (Figure 1).
In addition to the other viruses tested, EV-D68–posi-
tive specimens were screened for parainfluenza virus 1–4, 
coronaviruses (NL63, OC43, HKU1, 229E), and bocavirus. 
None of these viruses was detected in EV-D68–positive pa-
tients, which suggested that EV-D68 played a major role in 
causing respiratory disease.
Major symptoms associated with EV-D68 infection in-
cluded sudden onset, fever/shivers, cough, and sore throat 
(Table 1). Pneumonia was diagnosed in a 7-year-old boy 
and a 10-year-old girl, and a 2-year-old girl was hospital-
ized because of obstructive bronchitis. For 11 (44%) of 25 
case-patients, a concurrent chronic condition was reported: 
5 with a respiratory condition, 3 with a cardiac condition, 
2 with diabetes, and 1 with a neurologic disorder. EV-D68 
was detected in 10 children and 15 adults; 56% of these 
patients were male.
Patients infected with EV-D68 came from different 
federal states in Germany; no epidemic cluster or outbreak 
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was detected in the context of these patients. Syndromic 
surveillance data of corresponding sentinel practices 
showed only a partial coincidence of EV-D68–positive pa-
tients and an increase of ARI activity in the practice. How-
ever, the increase in ARI activity was probably caused by 
unrelated RV activity.
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Table 1. Demographic and clinical characteristics of 25 patients infected with enterovirus D68,	Germany,	weeks 32–44,	2014* 
Patient Week† 
Age,	














1 36 6/F Thuringia + + + + ILI No None 
2 36 42/M North	Rhine-
Westphalia 
+ + + + ILI No Respiratory 
system 
3 37 61/M North	Rhine-
Westphalia 
+ + + + ILI No Cardiac 
system 
4 37 42/F North	Rhine-
Westphalia 
– + + + ARI No Respiratory 
system 
5 38 11/M Thuringia + + + + ILI No None 
6 40 35/F Lower	Saxony + + + – ILI No Respiratory 
system,	
diabetes 
7 40 53/M North	Rhine-
Westphalia 
+ + + + ILI No Cardiac 
system 
8 41 2/M Thuringia + + + – ILI No None 
9 41 62/M Hesse + – + + ARI No None 
10 41 7/M Rheinland-
Palatinate 
+ + + + Pneumonia No Respiratory 
system 
11 42 8/F Bavaria NA NA + + ARI No None 
12 42 25/M Hesse + – + – ARI No None 
13 42 22/M Lower	Saxony + + + + ILI No None 
14 42 14/F Baden-
Württemberg 
– – + + ARI No None 
15 42 43/M Bavaria + – + + ARI No None 




17 43 3/F North	Rhine-
Westphalia 
+ + + – ILI No None 
18 43 12/F Bavaria + – + + ARI No None 
19 43 52/M Lower	Saxony + + + + ILI No Diabetes 
20 43 26/M North	Rhine-
Westphalia 
+ + + – ILI No None 
21 43 44/M North	Rhine-
Westphalia 
+ – + + ARI No Cardiac 
system 
22 43 2/F Hesse + + + – Obstructive 
bronchitis 
Yes None 
23 43 41/M Saarland + + + + ILI No None 
24 44 2/F Schleswig-
Holstein 
+ – + – ARI No None 
25 44 73/F North	Rhine-
Westphalia 






Sequence analysis is not regularly performed for rhi-
novirus/enterovirus–positive specimens within sentinel 
surveillance in Germany. However, comparative data can 
be provided for week 36 through week 20 for the 2009–10 
and 2010–11 seasons (Table 2). During those seasons, pa-
tients with ILI in 5 age groups (<1–4, 5–15, 16–34, 35–60, 
and >60 years) were investigated by using the rhinovirus/
enterovirus real-time reverse transcription PCR. Within 
the seasons, an average of 21% (198/952 for 2009–10) and 
13% (128/1002 for 2010–11) of specimens were positive 
for rhinovirus/enterovirus (Table 2). At least 20% of the 
rhinovirus/enterovirus–positive specimens were arbitrarily 
chosen for sequencing (mainly RV A, B, or C; 1 echovi-
rus), but no EV-D68 was identified.
Phylogenetic analysis of EV-D68 strains detected in 
Germany was conducted for the VP1 and the VP4/VP2 ge-
nomic regions (Figure 2). Analysis placed EV-D68 isolates 
from Germany into major groups 1 or 3 and clustered with 
strains from the United States and the Netherlands from 
2014, which indicated circulation of similar strains in the 
United States and Europe.
Conclusions
In the 2014 outbreak in the United States, ≈36% (2,600) of 
specimens were positive for EV-D68; children were pre-
dominantly affected. Because testing was prioritized for 
children with severe respiratory illness, there were prob-
ably more cases of mild infections (8). Information on 
EV-D68 circulation during this period for Europe is rare. 
This finding might be caused by insufficient sampling of 
patients with ARI or limited detection of EV-D68 by labo-
ratory diagnostics (9). Sporadic cases of neurologic disease 
after EV-D68 infection were reported from France and the 
United Kingdom (9,10).
Investigation for EV-D68 has been continuously per-
formed in the Netherlands since the increase in infections in 
2010 (13). The ILI/ARI sentinel system in the Netherlands 
identified 24 EV-D68 infections in 2010, none in 2011, 7 in 
2012, 3 in 2013, and 5 in 2014 (by week 40) (13,14), which 
probably increased toward the end of that year (9). For the 
2014 season, a hospital in the Netherlands reported an in-
crease of EV-D68; 16 patients were infected (12). Such an 
increase in EV-D68 infections was already seen in 2010 at 
the same hospital along with an increased number of cases 
throughout the country (13). This finding increased the pos-
sibility that an increase in EV-D68 infections in primary 
care will also extend to increased numbers of infections in 
patients in secondary care. So far, we report low EV-D68 
circulation in Germany: 25 sporadic cases in 2014.
Clinical patterns in patients in Germany were largely 
determined by the ILI/ARI case definition for collecting 
specimens. Most (88%) patients had mild disease. Severe 
disease was observed in 3 children who had obstructive 
bronchitis and pneumonia, and 1 child required hospital 
care. Similarly, mild respiratory disease was predomi-
nantly observed for patients in the Netherlands (14). How-
ever, more severe cases were detected among hospitalized 
children who had life-threatening respiratory illness, as 
described in the United States (6,12,14). More than half 
of patients with severe respiratory illness in Germany and 
the Netherlands had concurrent conditions (12,14), which 
seem to be a major factor for development of severe disease 
after EV-D68 infection (6).
Phylogenetic analysis of EV-D68 from Germany 
showed high similarity with current strains from the Unit-
ed States and the Netherlands (12,14). These new genetic 
clusters reflect the evolution of EV-D68 and might be as-
sociated with an increasing activity of this virus. For an 
improved understanding of the factors determining local 
and temporal differences in respiratory disease outbreaks, 
continuous collection of global data by representative sur-



















 <1–4 156 45	(29) 11 11 0 
 5–15 386 71 (18) 18 17 1† 
 16–34 225 40 (18) 12 12 0 
 35–60 157 34 (22) 19 19 0 
 >60 28 8	(29) 4 4 0 
 Total 952 198	(21) 64 63 1 
2010–2011 
 <1–4 271 56 (21) 21 21 0 
 5–15 363 40 (11) 20 20 0 
 16–34 189 20 (11) 17 17 0 
 35–60 153 12	(9) 11 11 0 
 >60 26 0 (0) 0 0 0 












identical in both trees because complementary VP1 and VP4/VP2 sequence data are not available for all reference viruses.  
Major	groups	1,	2,	and	3	are	shown	as	described	by	Meijer	et	al.	(13,14). Only bootstrap values >65% are shown at branch  
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